FBRX News and Press, Forte Biosciences Inc. From 09/03/21

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

A wide variety of news items drove some high-profile moves in Friday's midday trading. Earnings remained a key theme, with Broadcom (NASDAQ:AVGO) and MongoDB (NASDAQ:MDB) both posting gains on strong quarterly reports. Elsewhere, Impel NeuroPharma (NASDAQ:IMPL) recorded a double-digit percent...

Gainers: Cellect Biotechnology (NASDAQ:APOP) +29%. Katapult (NASDAQ:KPLT) +27%. Innate Pharma (NASDAQ:IPHA) +25%. MongoDB  (NASDAQ:MDB) +24%. Draganfly (NASDAQ:DPRO) +22%. Future FinTech (NASDAQ:FTFT) +18%. Neonode (NASDAQ:NEON) +18%. Impel NeuroPharma (NASDAQ:IMPL) +15%. The L.S. Starre...

Shares of Forte Biosciences (NASDAQ: FBRX) are imploding on Friday, plunging 81.4% lower as of 11:12 a.m. This huge decline came after the company announced on Thursday evening that top-line data from its phase 2 study evaluating FB-401 in treating atopic dermatitis hadn't met the p...

Gainers: Cellect Biotechnology (NASDAQ:APOP) +39%. NeuroOne Medical Technologies (NASDAQ:NMTC) +17%. Enveric Biosciences (NASDAQ:ENVB) +16%. Impel NeuroPharma (NASDAQ:IMPL) +12%. Progenity (NASDAQ:PROG) +10%. Losers: Forte Biosciences (NASDAQ:FBRX) -81%. Evelo Biosciences (NASDAQ:EV...

Forte Biosciences (NASDAQ:FBRX) -80% after scrapping development of FB-401 treatment Sphere 3D (NASDAQ:ANY) -27% on raising $192.1M to secure the initial order of 60,000 miners JOANN (NASDAQ:JOAN) -16% on Q2 earnings release. Yext (NYSE:YEXT) -12% on Q2...

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced that topline data from its Phase 2 clinical trial of FB-401 for the treatment of atopic dermatitis failed to meet statistical significance for the primary endpo...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Earnings news remained the central theme of single-stock stories during Tuesday's midday action. Sea Limited (NYSE:SE) was one of the standouts, as a rare profit beat inspired a notable gain in the company's stock. Global-e Online (NASDAQ:GLBE) also saw gains in the wake of its quarterly repo...

LM Funding America LMFA +24% on Q2 earnings. Forte Biosciences (NASDAQ:FBRX) +17%. Powerbridge Technologies PBTS +14% on signing pact with Cryptodigital to acquire bitcoin and ethereum miners Danimer Scientific DNMR +13% on Q2 earnings. Helius Medical Technologie...